Literature DB >> 12361077

Increased expression of inducible nitric oxide synthase for human oral submucous fibrosis, verrucous hyperplasia, and verrucous carcinoma.

Y K Chen1, S S Hsuen, L M Lin.   

Abstract

Three isoforms of nitric oxide synthase (NOS), endothelial, neuronal and inducible NOS (iNOS), have been identified in humans. Enhanced expression of iNOS protein has been previously reported for human oral epithelial dysplasias, a human oral premalignant epithelial lesion; however, this expression has not been demonstrated for other premalignant epithelial lesions, namely, oral submucous fibrosis (SF) and verrucous hyperplasia (VH). On the other hand, iNOS protein expression has not been reported in human oral verrucous carcinoma (VCa). The aim of this current study was to determine whether iNOS protein also occurs for oral SF, VH and VCa lesions. We found that membranous stainings were observed chiefly in oral SF lesions (17/20, 85%), whereas cytoplasmic stainings were mainly found in the VH variants (16/20, 80%). By contrast, cytoplasmic and/or nuclear stainings were observed in the specimens of verrucous carcinoma (17/20, 85%). Since no iNOS activity could be detected for any of our specimens of normal buccal mucosa in the present immunohistochemical study, this suggests that an NOS-dependent mechanism may be involved in the malignant transformation of these two premalignant oral epithelial lesions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12361077     DOI: 10.1054/ijom.2002.0246

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  3 in total

1.  Verrucous Hyperplasia: Case report and differential diagnosis.

Authors:  Sonal Grover; Mihir Jha; Bhushan Sharma; Shekhar Kapoor; Kumud Mittal; Nithin K Parakkat; Anil B Shivappa; Ravleen Kaur
Journal:  Sultan Qaboos Univ Med J       Date:  2017-03-30

2.  A Case-control Study Comparing and Correlating iNOS Expression among Various Clinicopathological Variants of Oral Leukoplakia and Oral Squamous Cell Carcinoma: A Immunohistochemistry Study.

Authors:  Deepak N Singh; Kumar Chandan Srivastava; Aparna D Potsangbam; Deepti Shrivastava; Doddabasavaiah Basavapur Nandini; Wahengbam T Singh; Koijam S Singh
Journal:  J Pharm Bioallied Sci       Date:  2020-08-28

3.  Zyflamend reduces LTB4 formation and prevents oral carcinogenesis in a 7,12-dimethylbenz[alpha]anthracene (DMBA)-induced hamster cheek pouch model.

Authors:  Peiying Yang; Zheng Sun; Diana Chan; Carrie A Cartwright; Mary Vijjeswarapu; Jibin Ding; Xiaoxin Chen; Robert A Newman
Journal:  Carcinogenesis       Date:  2008-08-06       Impact factor: 4.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.